Abstract
STING is a newly identified adaptor protein for sensing cytosolic nucleic acid. It is well established that STING plays a crucial role in innate immune response via inducing production of type I IFN. Emerging evidence suggests that the activation of STING-dependent signaling is also implicated in the process of cell death, such as apoptosis, pyroptosis, necroptosis, and autophagy. Of note, the pro-death outcome is even predominant in certain cell types, like lymphocytes, myeloid cells, and hepatocytes. Given that STING agonists are being tested for enhancing antitumor immune responses, it is necessary to fully understand the outcome of STING activation. The anti-microorganism response mediated by STING has been well described; therefore, we focus on the role of STING-dependent signaling on cell death in this review.
Similar content being viewed by others
References
Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455(7213):674–U74. https://doi.org/10.1038/nature07317.
Ng KW, Marshall EA, Bell JC, Lam WL. cGAS–STING and cancer: dichotomous roles in tumor immunity and development. Trends Immunol. 2017.
Barber GN. STING: infection, inflammation and cancer. Nat Rev Immunol. 2015;15(12):760–70.
Ahn J, Barber GN. Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease. Curr Opin Immunol. 2014;31:121–6. https://doi.org/10.1016/j.coi.2014.10.009.
West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520(7548):553–+. https://doi.org/10.1038/nature14156.
Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786–91. https://doi.org/10.1126/science.1232458.
Cai X, Chiu Y-H, Chen ZJ. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell. 2014;54(2):289–96. https://doi.org/10.1016/j.molcel.2014.03.040.
Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 2011;478(7370):515–U111. https://doi.org/10.1038/nature10429.
Woodward JJ, Iavarone AT, Portnoy DA. C-di-AMP secreted by intracellular listeria monocytogenes activates a host type I interferon response. Science. 2010;328(5986):1703–5. https://doi.org/10.1126/science.1189801.
Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11(7):1018–30. https://doi.org/10.1016/j.celrep.2015.04.031.
Woo S-R, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MYK, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41(5):830–42. https://doi.org/10.1016/j.immuni.2014.10.017.
Gao P, Zillinger T, Wang W, Ascano M, Dai P, Hartmann G, et al. Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA. Cell Rep. 2014;8(6):1668–76. https://doi.org/10.1016/j.celrep.2014.08.010.
Luo M, Wang H, Wang Z, Cai H, Lu Z, Li Y, et al. A STING-activating nanovaccine for cancer immunotherapy. Nat Nanotechnol. 2017;12(7):648–+. https://doi.org/10.1038/nnano.2017.52.
Fu J, Kanne DB, Leong M, Glickman LH, McWhirter SM, Lemmens E, et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci Transl Med. 2015;7(283):283ra52. https://doi.org/10.1126/scitranslmed.aaa4306.
Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014;41(5):843–52. https://doi.org/10.1016/j.immuni.2014.10.019.
Corrales L, McWhirter SM, Dubensky TW Jr, Gajewski TF. The host STING pathway at the interface of cancer and immunity. J Clin Investig. 2016;126(7):2404–11. https://doi.org/10.1172/jci86892.
Cheng N, Watkins-Schulz R, Junkins RD, David CN, Johnson BM, Montgomery SA, et al. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer. JCI Insight. 2018;3(22). https://doi.org/10.1172/jci.insight.120638.
Wilson DR, Sen R, Sunshine JC, Pardoll DM, Green JJ, Kim YJ. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy. Nanomedicine. 2018;14(2):237–46. https://doi.org/10.1016/j.nano.2017.10.013.
Hanson MC, Crespo MP, Abraham W, Moynihan KD, Szeto GL, Chen SH, et al. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. J Clin Invest. 2015;125(6):2532–46. https://doi.org/10.1172/JCI79915.
Aroh C, Wang Z, Dobbs N, Luo M, Chen Z, Gao J, et al. Innate immune activation by cGMP-AMP nanoparticles leads to potent and long-acting antiretroviral response against HIV-1. J Immunol. 2017;199(11):3840–8. https://doi.org/10.4049/jimmunol.1700972.
An M, Yu C, Xi J, Reyes J, Mao G, Wei WZ, et al. Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity. Nanoscale. 2018;10(19):9311–9. https://doi.org/10.1039/c8nr01376d.
Ramanjulu JM, Pesiridis GS, Yang J, Concha N, Singhaus R, Zhang SY, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018;564(7736):439–43. https://doi.org/10.1038/s41586-018-0705-y.
Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155(3):688–98. https://doi.org/10.1016/j.cell.2013.09.049.
Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, et al. Signalling strength determines proapoptotic functions of STING. Nat Commun. 2017;8(1):427. https://doi.org/10.1038/s41467-017-00573-w.
Moretti J, Roy S, Bozec D, Martinez J, Chapman JR, Ueberheide B, et al. STING senses microbial viability to orchestrate stress-mediated autophagy of the endoplasmic reticulum. Cell. 2017;171(4):809–23 e13. https://doi.org/10.1016/j.cell.2017.09.034.
Tang CH, Zundell JA, Ranatunga S, Lin C, Nefedova Y, Del Valle JR, et al. Agonist-mediated activation of STING induces apoptosis in malignant B cells. Cancer Res. 2016;76(8):2137–52. https://doi.org/10.1158/0008-5472.CAN-15-1885.
Sze A, Belgnaoui SM, Olagnier D, Lin R, Hiscott J, van Grevenynghe J. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe. 2013;14(4):422–34. https://doi.org/10.1016/j.chom.2013.09.009.
Cui Y, Zhao D, Sreevatsan S, Liu C, Yang W, Song Z, et al. Mycobacterium bovis induces endoplasmic reticulum stress mediated-apoptosis by activating IRF3 in a murine macrophage cell line. Front Cell Infect Microbiol. 2016;6:182. https://doi.org/10.3389/fcimb.2016.00182.
Petrasek J, Iracheta-Vellve A, Csak T, Satishchandran A, Kodys K, Kurt-Jones EA, et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc Natl Acad Sci U S A. 2013;110(41):16544–9. https://doi.org/10.1073/pnas.1308331110.
Iracheta-Vellve A, Petrasek J, Gyongyosi B, Satishchandran A, Lowe P, Kodys K, et al. Endoplasmic reticulum stress-induced hepatocellular death pathways mediate liver injury and fibrosis via stimulator of interferon genes. J Biol Chem. 2016;291(52):26794–805. https://doi.org/10.1074/jbc.M116.736991.
Qiao JT, Cui C, Qing L, Wang LS, He TY, Yan F, et al. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. Metabolism. 2018;81:13–24. https://doi.org/10.1016/j.metabol.2017.09.010.
Webster SJ, Brode S, Ellis L, Fitzmaurice TJ, Elder MJ, Gekara NO, et al. Detection of a microbial metabolite by STING regulates inflammasome activation in response to chlamydia trachomatis infection. PLoS Pathog. 2017;13(6):e1006383. https://doi.org/10.1371/journal.ppat.1006383.
Man SM, Karki R, Malireddi RK, Neale G, Vogel P, Yamamoto M, et al. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol. 2015;16(5):467–75. https://doi.org/10.1038/ni.3118.
Gaidt MM, Ebert TS, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell. 2017;171(5):1110–24 e18. https://doi.org/10.1016/j.cell.2017.09.039.
Schock SN, Chandra NV, Sun Y, Irie T, Kitagawa Y, Gotoh B, et al. Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway. Cell Death Differ. 2017;24(4):615–25. https://doi.org/10.1038/cdd.2016.153.
Brault M, Olsen TM, Martinez J, Stetson DB, Oberst A. Intracellular nucleic acid sensing triggers necroptosis through synergistic type I IFN and TNF signaling. J Immunol. 2018;200(8):2748–56. https://doi.org/10.4049/jimmunol.1701492.
Bhatelia K, Singh K, Prajapati P, Sripada L, Roy M, Singh R. MITA modulated autophagy flux promotes cell death in breast cancer cells. Cell Signal. 2017;35:73–83. https://doi.org/10.1016/j.cellsig.2017.03.024.
White MJ, McArthur K, Metcalf D, Lane RM, Cambier JC, Herold MJ, et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell. 2014;159(7):1549–62. https://doi.org/10.1016/j.cell.2014.11.036.
Rongvaux A, Jackson R, Harman CCD, Li T, West AP, de Zoete MR, et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell. 2014;159(7):1563–77. https://doi.org/10.1016/j.cell.2014.11.037.
Larkin B, Ilyukha V, Sorokin M, Buzdin A, Vannier E, Poltorak A. Cutting edge: activation of STING in T cells induces type I IFN responses and cell death. J Immunol. 2017;199(2):397–402. https://doi.org/10.4049/jimmunol.1601999.
Divangahi M, Behar SM, Remold H. Dying to live: how the death modality of the infected macrophage modulates immunity to tuberculosis. In: Divangahi M, editor. New Paradigm of Immunity to Tuberculosis. Adv Exp Med Biol, 2013. p. 103–120.
Orzalli MH, Kagan JC. Apoptosis and necroptosis as host defense strategies to prevent viral infection. Trends Cell Biol. 2017;27(11):800–9. https://doi.org/10.1016/j.tcb.2017.05.007.
Chattopadhyay S, Kuzmanovic T, Zhang Y, Wetzel JL, Sen GC. Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral pathogenesis. Immunity. 2016;44(5):1151–61. https://doi.org/10.1016/j.immuni.2016.04.009.
McArthur K, Whitehead LW, Heddleston JM, Li L, Padman BS, Oorschot V, et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science. 2018;359(6378):eaao6047. https://doi.org/10.1126/science.aao6047.
Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265(1):130–42. https://doi.org/10.1111/imr.12287.
Corrales L, Woo SR, Williams JB, McWhirter SM, Dubensky TW Jr, Gajewski TF. Antagonism of the STING pathway via activation of the AIM2 inflammasome by intracellular DNA. J Immunol. 2016;196(7):3191–8. https://doi.org/10.4049/jimmunol.1502538.
Banerjee I, Behl B, Mendonca M, Shrivastava G, Russo AJ, Menoret A, et al. Gasdermin D restrains type I interferon response to cytosolic DNA by disrupting ionic homeostasis. Immunity. 2018;49(3):413–26 e5. https://doi.org/10.1016/j.immuni.2018.07.006.
Chen D, Tong J, Yang L, Wei L, Stolz DB, Yu J, et al. PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors. Proc Natl Acad Sci U S A. 2018;115(15):3930–5. https://doi.org/10.1073/pnas.1717190115.
Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–41. https://doi.org/10.1016/j.cell.2011.10.026.
Kobayashi S. Choose delicately and reuse adequately: the newly revealed process of autophagy. Biol Pharm Bull. 2015;38(8):1098–103. https://doi.org/10.1248/bpb.b15-00096.
Zhang Y, Whaley-Connell AT, Sowers JR, Ren J. Autophagy as an emerging target in cardiorenal metabolic disease: from pathophysiology to management. Pharmacol Ther. 2018;191:1–22. https://doi.org/10.1016/j.pharmthera.2018.06.004.
White E. The role for autophagy in cancer. J Clin Investig. 2015;125(1):42–6. https://doi.org/10.1172/jci73941.
Efeyan A, Comb WC, Sabatini DM. Nutrient-sensing mechanisms and pathways. Nature. 2015;517(7534):302–10. https://doi.org/10.1038/nature14190.
Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol. 2015;16(8):461–72. https://doi.org/10.1038/nrm4024.
Liu Y, Levine B. Autosis and autophagic cell death: the dark side of autophagy. Cell Death Differ. 2015;22(3):367–76. https://doi.org/10.1038/cdd.2014.143.
Roos WP, Thomas AD, Kaina B. DNA damage and the balance between survival and death in cancer biology. Nat Rev Cancer. 2016;16(1):20–33. https://doi.org/10.1038/nrc.2015.2.
Liang Q, Seo GJ, Choi YJ, Ge J, Rodgers MA, Shi M, et al. Autophagy side of MB21D1/cGAS DNA sensor. Autophagy. 2014;10(6):1146–7. https://doi.org/10.4161/auto.28769.
Moretti J, Blander JM. Detection of a vita-PAMP STINGs cells into reticulophagy. Autophagy. 2018;14(6):1102–4. https://doi.org/10.1080/15548627.2018.1441471.
Watson RO, Bell SL, MacDuff DA, Kimmey JM, Diner EJ, Olivas J, et al. The cytosolic sensor cGAS detects mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe. 2015;17(6):811–9. https://doi.org/10.1016/j.chom.2015.05.004.
Liu Y, Gordesky-Gold B, Leney-Greene M, Weinbren NL, Tudor M, Cherry S. Inflammation-induced, STING-dependent autophagy restricts Zika virus infection in the drosophila brain. Cell Host Microbe. 2018;24(1):57–68 e3. https://doi.org/10.1016/j.chom.2018.05.022.
Liu D, Wu H, Wang C, Li Y, Tian H, Siraj S, et al. STING directly activates autophagy to tune the innate immune response. Cell Death Differ. 2018. https://doi.org/10.1038/s41418-018-0251-z.
Author contributions’ statement
F.S. and S.L. wrote the manuscript. Z.L. collected the references and revised the manuscript. Z.Y. helped in language editing. W.G. supervised the review.
Funding
This study is supported by the National Natural Science Foundation of China (81602103), Natural Science Foundation of Jiangsu Province (BK20160114), Distinguished Young Scholar Project of Medical Science and Technology Development Foundation of Nanjing Department of Health (JQX17005), Key Project of Medical Science and Technology Development Foundation of Nanjing Department of Health (YKK16114), Medical Research Program of Jiangsu Provincial Commission of Health and Family Planning (Q2017007), and Wu Jieping Medical Foundation (320.2710.1817).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sun, F., Liu, Z., Yang, Z. et al. The emerging role of STING-dependent signaling on cell death. Immunol Res 67, 290–296 (2019). https://doi.org/10.1007/s12026-019-09073-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-019-09073-z